Search

Displaying results 4451 - 4460 of 8575 in total
  1. Drug

    Selepressin

    go.drugbank.com/drugs/DB12495
    Investigational

    Selepressin has been used in trials studying the treatment of Septic Shock.

  2. Drug

    Imiglitazar

    go.drugbank.com/drugs/DB12511
    Investigational

    Imiglitazar has been used in trials studying the treatment of Diabetes Mellitus.

  3. Drug

    SAR-405838

    go.drugbank.com/drugs/DB12541
    Investigational

    SAR405838 has been used in trials studying the treatment of Neoplasm Malignant.

  4. Drug

    Urapidil

    go.drugbank.com/drugs/DB12661
    Investigational

    Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.

  5. Drug

    Intepirdine

    go.drugbank.com/drugs/DB12680
    Investigational

    Intepirdine has been used in trials studying the treatment of Alzheimer's Disease.

  6. Drug

    Balugrastim

    go.drugbank.com/drugs/DB12699
    Investigational

    Balugrastim has been used in trials studying the treatment of Solid Tumors.

  7. Drug

    Solamargine

    go.drugbank.com/drugs/DB12700
    Investigational

    Solamargine has been used in trials studying the treatment of Actinic Keratosis.

  8. Drug

    Pridopidine

    go.drugbank.com/drugs/DB11947
    Investigational

    Pridopidine has been used in trials studying the treatment of Huntington's Disease.

  9. Drug

    Evatanepag

    go.drugbank.com/drugs/DB12022
    Investigational

    Evatanepag has been used in trials studying the treatment of Tibial Fractures.

  10. Drug

    EMZ702

    go.drugbank.com/drugs/DB05021
    Investigational

    EMZ702 has an excellent safety profile and the combination of EMZ702 with interferon and ribavirin in surrogate models for hepatitis C has demonstrated a two to three fold increase in anti-viral potency … EMZ702, a non-toxic agent that has strong anti-viral synergy with interferon, is an ideal candidate for combination with current standard hepatitis C treatments.